{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:52:18Z","timestamp":1791409938997,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110299","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:04:29Z","timestamp":1785103469000},"page":"110299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fourth-generation allosteric EGFR inhibitors: Structure-based scaffold analysis and SAR exploration"],"prefix":"10.1016","volume":"181","author":[{"given":"Ibrahim Mohammed","family":"Hepishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo'men","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"El-morsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"El-Adl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bioorg.2026.110299_bb0005","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.3390\/jcm13216391","article-title":"EGFR-targeted therapies: a literature review","volume":"13","author":"Sha","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioorg.2026.110299_bb0010","doi-asserted-by":"crossref","first-page":"117677","DOI":"10.1016\/j.ejmech.2025.117677","article-title":"Annual review of EGFR inhibitors in 2024","volume":"292","author":"Gao","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110299_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1120278","article-title":"Novel considerations on EGFR-based therapy as a contributor to cancer cell death in NSCLC","volume":"13","author":"Peng","year":"2023","journal-title":"Front. Oncol."},{"issue":"27","key":"10.1016\/j.bioorg.2026.110299_bb0020","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1039\/D3RA02347H","article-title":"Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review","volume":"13","author":"Mansour","year":"2023","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110299_bb0025","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/1078-0432.CCR-14-2789","article-title":"EGFR mutations and resistance to irreversible pyrimidine-based EGFR inhibitors","volume":"21","author":"Ercan","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110299_bb0030","doi-asserted-by":"crossref","first-page":"108878","DOI":"10.1016\/j.bioorg.2025.108878","article-title":"Pan-EGFR inhibitor targeting EGFR 19del, L858R\/T790M and C797S triple-mutations: design, synthesis, and pharmacological evaluation","volume":"164","author":"Wang","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"7605","key":"10.1016\/j.bioorg.2026.110299_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature17960","article-title":"Overcoming EGFR (T790M) and EGFR (C797S) resistance with mutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110299_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082834","article-title":"Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis","volume":"390","author":"Ma","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.bioorg.2026.110299_bb0045","series-title":"C797S Resistance: The Undruggable EGFR Mutation in Non-small Cell Lung cancer?","first-page":"779","author":"Grabe","year":"2018"},{"key":"10.1016\/j.bioorg.2026.110299_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102664","article-title":"The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancer","volume":"122","author":"Ciardiello","year":"2024","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110299_bb0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","article-title":"Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance","volume":"15","author":"Fu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110299_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811601","article-title":"Various subtypes of EGFR mutations in patients with NSCLC define genetic, immunologic diversity and possess different prognostic biomarkers","volume":"13","author":"Lei","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110299_bb0065","doi-asserted-by":"crossref","first-page":"16556","DOI":"10.1021\/acsomega.8b03256","article-title":"Investigating the selectivity of allosteric inhibitors for mutant T790M EGFR over wild type using molecular dynamics and binding free energy calculations","volume":"3","author":"Tinivella","year":"2018","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110299_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00249-022-01594-0","article-title":"Systematic analysis and molecular profiling of EGFR allosteric inhibitor cross-reactivity across the proto-oncogenic ErbB family kinases by integrating dynamics simulation, energetics calculation and biochemical assay","volume":"51","author":"Ma","year":"2022","journal-title":"Eur. Biophys. J."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110299_bb0075","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/cbdd.14033","article-title":"Insights into the negative regulation of EGFR upon the binding of an allosteric inhibitor","volume":"99","author":"Li","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2026.110299_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128718","article-title":"Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLC","volume":"68","author":"Gero","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110299_bb0085","series-title":"Combination of Allosteric and Orthosteric EGFR Inhibitors for Treating Non-small-Cell Lung cancer","first-page":"342","author":"Sabnis","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110299_bb0090","doi-asserted-by":"crossref","first-page":"117178","DOI":"10.1016\/j.ejmech.2024.117178","article-title":"From challenges to solutions: a review of fourth-generation EGFR tyrosine kinase inhibitors to overcome the C797S triple mutation in non-small cell lung cancer","volume":"284","author":"Ahmad","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110299_bb0095","article-title":"Rational design of allosteric inhibitors targeting C797S mutant EGFR in NSCLC: an integrative in silico and in-vitro study","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"issue":"D1","key":"10.1016\/j.bioorg.2026.110299_bb0100","doi-asserted-by":"crossref","first-page":"D376","DOI":"10.1093\/nar\/gkad915","article-title":"ASD2023: towards the integrating landscapes of allosteric knowledgebase","volume":"52","author":"He","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.bioorg.2026.110299_bb0105","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110299_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70036","article-title":"Orthoallosteric EGFR-TKIs: a new paradigm in NSCLC treatment strategy targeting the C797S mutation","volume":"86","author":"Ahmad","year":"2025","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110299_bb0120","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/2159-8290.CD-18-0903","article-title":"Single and dual targeting of mutant EGFR with an allosteric inhibitor","volume":"9","author":"To","year":"2019","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110299_bb0125","first-page":"402","article-title":"Allosteric inhibition of drug resistant forms of EGFR L858R mutant NSCLC","volume":"3","author":"To, C","year":"2022","journal-title":"Nat. Cancer"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110299_bb0130","doi-asserted-by":"crossref","first-page":"13052","DOI":"10.1021\/acs.jmedchem.2c00893","article-title":"Discovery of novel allosteric EGFR L858R inhibitors for the treatment of non-small-cell lung cancer as a single agent or in combination with osimertinib","volume":"65","author":"Obst-Sander","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110299_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114856","article-title":"Discovery and optimization of 4-anilinoquinazoline derivatives spanning ATP binding site and allosteric site as effective EGFR-C797S inhibitors","volume":"244","author":"Dou","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110299_bb0140","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsmedchemlett.8b00564","article-title":"Discovery of potent and noncovalent reversible EGFR kinase inhibitors of EGFRL858R\/T790M\/C797S","volume":"10","author":"Li","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110299_bb0145","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","article-title":"A unique structure for epidermal growth factor receptor bound to GW572016 (lapatinib) relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells","volume":"64","author":"Wood","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110299_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104612","article-title":"Computational and synthetic approach with biological evaluation of substituted quinoline derivatives as small molecule L858R\/T790M\/C797S triple mutant EGFR inhibitors targeting resistance in non-small cell lung Cancer (NSCLC)","volume":"107","author":"Karnik","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110299_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114889","article-title":"Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: in vitro screening and ADME predictions","volume":"245","author":"Kardile","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110299_bb0160","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.bmc.2019.02.012","article-title":"Discovery of novel thienoquinoline-2-carboxamide chalcone derivatives as antiproliferative EGFR tyrosine kinase inhibitors","volume":"27","author":"Abdelbaset","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110299_bb0165","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1021\/acs.jmedchem.1c00848","article-title":"Design of a \u201ctwo-in-one\u201d mutant-selective epidermal growth factor receptor inhibitor that spans the orthosteric and allosteric sites","volume":"65","author":"Wittlinger","year":"2021","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110299_bb0170","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/acsmedchemlett.9b00381","article-title":"Discovery and optimization of dibenzodiazepinones as allosteric mutant-selective EGFR inhibitors","volume":"10","author":"De Clercq","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110299_bb0175","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1080\/07391102.2022.2071339","article-title":"Molecular dynamic simulations based discovery and development of thiazolidin-4-one derivatives as EGFR inhibitors targeting resistance in non-small cell lung cancer (NSCLC)","volume":"41","author":"Karnik","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110299_bb0180","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.1021\/acs.jmedchem.2c00168","article-title":"Conformational constrained 4-(1-Sulfonyl-3-indol) yl-2-phenylaminopyrimidine derivatives as new fourth-generation epidermal growth factor receptor inhibitors targeting T790M\/C797S mutations","volume":"65","author":"Chen","year":"2022","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110299_bb0185","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1021\/acs.jmedchem.3c00277","article-title":"Discovery of potent and wild-type-sparing fourth-generation EGFR inhibitors for treatment of osimertinib-resistance NSCLC","volume":"66","author":"Dong","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110299_bb0190","doi-asserted-by":"crossref","first-page":"130630","DOI":"10.1016\/j.bmcl.2026.130630","article-title":"Discovering potent EGFR inhibitors through the structural optimization of the Betti-base scaffold","volume":"137","author":"Xu","year":"2026","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110299_bb0195","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/s41467-022-30258-y","article-title":"Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors","volume":"13","author":"Beyett","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110299_bb0200","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.drudis.2021.02.005","article-title":"Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma","volume":"26","author":"Tripathi","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.110299_bb0205","series-title":"Natural Products as Enzyme Inhibitors: An Industrial Perspective","first-page":"1","article-title":"Fourth-generation allosteric EGFR tyrosine kinase inhibitors to combat the drug resistance associated with non-small cell lung Cancer (NSCLC)","author":"Ahmad","year":"2022"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:19:37Z","timestamp":1791407977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"alternative-id":["S0045206826008357"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110299","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fourth-generation allosteric EGFR inhibitors: Structure-based scaffold analysis and SAR exploration","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110299"}}